Vice Chair, Clinical Operations
Medical Director, Clinical Laboratory
Human DNA Identification Laboratory, Transplant Pathology, Surgical Pathology
Research interests include studies of mixed chimerism following solid organ and minimally ablative bone marrow transplantation.
Education and Training
BS Doane College, 1972
PhD (Physiology) Creighton University, 1978
MD University of Nebraska Med Center, 1986
Residency (Pathology) UNMC 1986-1990
Board Certified in Anatomic and Clinical Pathology, 1991
Medical Students: Lectures (Cell Injury, Tissue repair, inflammatory process, esophageal pathology, inflammatory bowel disease.)
Problem-based learning facilitator
Small group facilitator
Laboratory sessions on Inflammation and tissue repair, Gastrointestinal pathology, liver pathology.
Resident education - general surgical pathology, transplant pathology
Editorial Board or Reviewer:
American Journal of Gastroenterology
Abstract Review Panel, U.S. and Canadian Academy of Pathology
Board of Directors:
Nebraska Organ Retrieval System,
Pearsall N, Bhattacharya G, Wisecarver J, Adams J, Cosgrove D, Kimberling W. Usherin expression is highly conserved in mouse and human tissues. Hear Res 174:55-63, 2002.
Goal A, Baranowskia-Kortylewicz J, Hinrichs SH, Wisecarver J, Pavlinkova G, Augustine S, Colcher D, Booth BJ, Batra SK. 99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma. J Nucl Med; 42:1528-1529, 2001.
Rubocki RJ, McCue BJ, Duffy KJ, Shepard KL, Shepherd SJ, Wisecarver JL. Natural DNA mixtures generated in fraternal twins in utero. J Forensic Sci; 46:120-125, 2001.
Tempero M, Leichner P, Baranowska-Kortylewicz J, Harrison K, Augustine S, Schlom J, Anderson J, Wisecarver J, Colcher D. High-dose therapy with 90yttrium-labeled monoclonal antibody CC49: a phase I trial. Clin Can Res; 6:3095-3102, 2000.
Roberts CA, Radio SJ, Markin RS, Wisecarver JL, Langnas AM. Histopathologic evaluation of primary intestinal transplant recipients at autopsy: a single-center experience. Trans Proceed, 32:1202-1203, 2000.
Cauble MS, Gilroy R, Sorrell MF, Mailliard ME, Sudan DL, Anderson JC, Wisecarver JL, Balakrishnan S, Larsen JL. Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence following liver transplantation. Transplantation; 71:892-895, 2000.
For a detailed list of publications, click here.